Abiopharma

🔍 Sparks C Todd (Director)

Company: Triumph Financial, Inc. (TFIN)

Report Date: 2026-05-01

Detailed Transactions and Holdings:

• Acquired 1,258 shares of Common Stock (Direct)
  Date: 2026-05-01 | Code: A | equity_swap_involved: 0 | shares_owned_after: 50,757.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-05-01 | Code: H | nature_of_ownership: By Spouse | shares_owned_after: 5,959.00 | Footnotes: F3
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-05-01 | Code: H | nature_of_ownership: By SBS Equity, LLC | shares_owned_after: 122,119.00 | Footnotes: F3
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-05-01 | Code: H | nature_of_ownership: C. Todd Sparks FLP | shares_owned_after: 4,000.00 | Footnotes: F3

Footnotes:

• F1: Shares represented by time-vested restricted stock units that vest one year from date of award.
• F2: Consists of (i) 49,499 shares beneficially owned by reporting person, and (ii) 1,258 shares of restricted stock or restricted stock units of the reporting person subject to future vesting requirements.
• F3: Reporting person exercises voting and dispositive control over these shares and disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest.